Dr. Louis Kirby, M.D., medical director for Pivotal Research Centers, agrees; “Pivotal Research is pleased to be part of the study team in assisting GW Medical in their Phase II clinical trials. A new test to diagnose Alzheimer’s disease earlier, such as their LymPro Test, could lead to expedited therapeutic intervention and an improved quality of life for those individuals affected by AD.”